Sirtex Medical and Magle Group sign distribution and collaboration agreement

Sirtex Medical announced a collaboration and exclusive worldwide distribution agreement with Magle Group for EmboCept S DSM 50 μm, a chemoembolization product for liver and lung tumors. Sirtex will exclusively distribute the product and both companies will pursue a joint development plan.

“We are delighted to team up with Sirtex to unleash the full commercial potential of EmboCept S, our proprietary product for chemoembolization of inoperable liver and lung tumours.”prnewswire.com

• 1 source
• prnewswire.comSirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept® S DSM 50 μmSirtexSep 8, 2023

Summarized from public sources; check the original articles before acting on it.